Chai Discovery
AI Drug Discovery
5 open rolesAI Drug DiscoverySan Francisco, United States29 employees$230M raisedEst. 2024
General Catalyst
Thrive Capital
Menlo Ventures
Oak HC/FT
OpenAI
Dimension
About Chai Discovery
- Chai Discovery builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
- They are developing foundation models for biology and drug discovery to transform how biopharma creates new therapies.
Chai Discovery is listed on Rocketlist with 5 active roles. The company is categorized as AI Drug Discovery in BioTech. Chai Discovery is at Series B stage, with a B2B business model, headquartered in San Francisco, United States. Chai Discovery was founded in 2024 and has 29 employees. Chai Discovery has raised $230M. Active roles are refreshed daily from public hiring sources.